BLFS today
$38.61+$1.31 (+3.51%)close Oct 5, 2026Trend
DailyUptrend (confirmed)
4 hourLeaning Bullish
1 hourExpanding
15 minAscending Triangle
5 minStrong Bullish
Daily trend turns down below $34.89
Key levels
Resistance$41.75
Resistance$39.76
Support$38.10
Support$36.91
Nasdaq · Healthcare
BIOLIFE SOLUTIONS INC (BLFS)
What Is the Price Target for BLFS?
SEPT Low Target
$26.35
SEPT Mid Target
$31.00
SEPT High Target
$35.65
Analyst Consensus
$31.00
Is BLFS a Buy or Sell Right Now?
Thesis
- •Revenue growing 28.9% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BLFS.
Start Free Trial →Is BLFS Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$12.89
49
Moat Score
NARROW
6/9
Piotroski Score
32.4
Altman Z-Score
What Is Smart Money Doing with BLFS?
Insider Signal
NEUTRAL
0 buys / 3 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Wichterman Troy | officer | Buy | 76,204 | - | Oct 6, 2026 |
| Wichterman Troy | officer | Buy | 62,300 | - | Oct 6, 2026 |
| Wichterman Troy | officer | Sale | 95,933 | $3.7M | Oct 6, 2026 |
| Wichterman Troy | officer | Sale | 256,000 | - | Oct 6, 2026 |
| GOSWAMI JOYDEEP | director | Sale | 53,156 | - | Oct 6, 2026 |
| Ellingson Rachel | director | Sale | 57,995 | - | Oct 6, 2026 |
| DuRoss Amy | director | Sale | 26,857 | - | Oct 6, 2026 |
| Coste Catherine | director | Sale | 13,871 | - | Oct 6, 2026 |
| DE GREEF RODERICK | director officer | Buy | 225,670 | - | Oct 6, 2026 |
| DE GREEF RODERICK | director officer | Buy | 237,460 | - | Oct 6, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BLFS Growth Story
Revenue YoY
28.9%
3yr Revenue CAGR
8.1%
EPS Growth YoY
77.27%
FCF Growth YoY
104.4%
Revenue Trend
ACCELERATING
Dark Pool Trades for BLFS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BLFS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:37:44 | $38.61 | 8,500 | $$328K | SELL |
| 21:37:44 | $38.61 | 43,900 | $$1.7M | SELL |
| 20:00:37 | $38.61 | 45,295 | $$1.7M | SELL |
| 20:00:01 | $38.61 | 1,820 | $$70K | BUY |
| 20:00:01 | $38.61 | 1,179 | $$46K | BUY |
5 dark pool trades shown · $$3.9M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for BIOLIFE SOLUTIONS INC (BLFS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BLFS — frequently asked questions
What is BLFS stock price today?
BIOLIFE SOLUTIONS INC (BLFS) is at $38.61, up 3.51% (+$1.31) at the Oct 5, 2026 close.
Why is BLFS stock moving today?
Latest BLFS news — Nov 3, 2026: Repligen to Buy BioLife Solutions, Company Says
What is the BLFS price target?
The average analyst price target for BLFS is $31.00, ranging from $31 to $31, based on 4 analysts. Latest: Stephens & Co. downgrade on Jul 27, 2026.
What do analysts rate BLFS?
Analyst ratings for BLFS: 0 Buy, 0 Hold, 5 Sell — consensus Sell.
Did BLFS beat earnings?
BLFS last reported on Aug 6, 2026: EPS $0.91 vs $0.03 expected — a beat of 2807.3%.
Does BLFS pay a dividend?
BLFS does not currently pay a dividend.
How much debt does BLFS have?
BIOLIFE SOLUTIONS INC reported $0M of debt and $24M of cash (Jun 30, 2026).
What are BLFS support and resistance levels?
Support: $38.10, $36.91, $34.89. Resistance: $39.76, $41.75, $42.87.
What are insiders doing with BLFS?
Insider activity: NEUTRAL, 0 buys and 3 sells in the last 90 days.
What is the latest news on BLFS?
Nov 3, 2026: Repligen to Buy BioLife Solutions, Company Says